Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
PolandAll drugs from this manufacturer
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
This medicine is used in adults with multiple myeloma. It may be administered alone with dexamethasone or in combination with two other medicines (bortezomib and dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC: L04AX06
-
This medicine is used in adults to treat multiple myeloma (a type of malignant cancer that affects white blood cells). It may be used alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC: L04AX06
-
The medicine is used in adults with multiple myeloma, a type of malignant tumor that affects white blood cells.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC: L04AX06
-
The medicine is used in adults with multiple myeloma. It may be administered alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC: L04AX06